Abbott E-Mails Could Affect Patent Evergreening Suits
While efforts by pharmaceutical companies to protect market share have always drawn the scrutiny of regulators, recently uncovered documents from Abbott Laboratories have cast a new light on some of these...To view the full article, register now.
Already a subscriber? Click here to view full article